Surgical menopause and cardiovascular risks
Related Experiment Video
Updated: Jul 15, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
1Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA. ral35@columbia.edu
Objective And Design:
To review the relevant literature on the effect of surgical menopause on cardiovascular disease (CVD).
Results And Conclusions:
Early menopause (before age 50) is associated with an increased risk of CVD. Bilateral oophorectomy around the time of menopause may impart either a small influence or no effect on increasing the risk of CVD; however, bilateral oophorectomy before menopause significantly increases the risk. Some data suggest a protective effect of estrogen therapy in this setting exist. The CVD risk is principally that of coronary heart disease and not cerebrovascular disease. Mortality rates may be increased in women with early menopause, either spontaneous or surgically induced. Hysterectomy per se, without bilateral oophorectomy, does not seem to increase CVD risk.
Related Concept Videos
Menopause
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Disorders of the Female Reproductive System
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Mitral Stenosis III: Medical Management

